Sana Biotechnology
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
188 E Blaine St, Seattle, Washington, 98...Phone Number
(206) 701-7914Website
www.sana.comRevenue
$252.9 MillionStock Symbol
SANAIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
4
1
2
3
4
2
About Sana Biotechnology
Sana Biotechnology is a biotechnology research and development company focused on creating engineered cells as medicines for patients. Founded in 2018, the company specializes in developing therapies that repair and control genes and replace missing or damaged cells. Sana Biotechnology aims to make these innovative treatments broadly available to patients with various diseases. The company operates research facilities in multiple locations including Seattle, Cambridge, and South San Francisco, advancing its mission to transform disease treatment through cellular engineering and gene therapy technologies.Explore more
Sana Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sana Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Sana Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Sana Biotechnology has new funding data
Click to see if Sana Biotechnology had a recent Job posting/layoffs
Product Launch: Get notified when Sana Biotechnology launches new products
Sana Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Sana Biotechnology recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Sana Biotechnology
Check out if Sana Biotechnology is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Sana Biotechnology as Masked Content
Find more new buyers
Compare Similar Companies to Sana Biotechnology
Compare insights from companies similar to Sana Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sana Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sana Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sana Biotechnology.
Sana Biotechnology financials insights
Gather financial insights about Sana Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Other Financing Round
$821M
2021
Stock Offering
$587.5M
2026
Stock/Share Issuance
$69M
Sana Biotechnology Tech Stack
A closer look at the technologies used by Sana Biotechnology
See more technologies
Most Recent Scoops
Person-Based
Earnings, Financial Reporting, Finance
Open Position
Open Position
Open Position
Person-Based
Earnings, Medical Research, Clinical Operations, Finance
Sana Biotechnology News & Media
Sana Biotechnology to Present at September 2026 Investor Conferences
SEATTLE, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conferences in September. The presentations will feature a business overview and update.Sana Biotechnology Reports Second Quarter 2026 Financial Results and Business Updates
Continued progress toward starting SC451 Phase 1/2 trial, including GLP toxicology studies, SC451 process transfer to the contract manufacturer, and clinical trial readinessDid Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the...Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes
Peer-Reviewed Letter to the Editor Describes Updated Long-Term Findings Consistent with Initial Trial Data Featured in NEJM Article Published in 2025
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sana Biotechnology
Sign Up For FreeTo access detailed company insights
Sana Biotechnology is a biotechnology research and development company focused on creating engineered cells as medicines for patients. Founded in 2018, the company specializes in developing therapies that repair and control genes and replace missing or damaged cells. Sana Biotechnology aims to make these innovative treatments broadly available to p... Read More
